What is the purpose and interpretation of the Montoux (Mantoux) test for tuberculosis (TB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Purpose and Interpretation of the Mantoux Test for Tuberculosis

The Mantoux test (PPD skin test) is the standard method for identifying latent tuberculosis infection by measuring the immune response to tuberculin protein injected intradermally, with interpretation based on the size of induration and patient risk factors. 1, 2

Administration Technique

  • The test is administered using the Mantoux technique, involving intracutaneous injection of 0.1 mL of purified protein derivative (PPD) containing 5 tuberculin units (TU) into the volar or dorsal surface of the forearm 1, 2
  • A proper injection should produce a pale elevation of the skin (wheal) measuring 6-10 mm in diameter 1, 2
  • The test must be read by trained healthcare personnel between 48 and 72 hours after injection; patient self-reading is not acceptable 1, 2, 3
  • Only the induration (hardened area) should be measured in millimeters, not the erythema (redness) 1, 2, 3

Interpretation of Results

The interpretation of PPD test results depends on three key factors:

  1. The purpose of testing (diagnostic vs. screening)
  2. The prevalence of TB in the population being tested
  3. The individual's risk factors for TB infection and progression 1, 2

Risk-Based Interpretation Thresholds

  • ≥5 mm induration is positive in high-risk individuals:

    • HIV-positive persons
    • Recent contacts of TB cases
    • Persons with fibrotic changes on chest X-ray consistent with prior TB
    • Organ transplant recipients and other immunosuppressed patients (e.g., receiving TNF-alpha inhibitors) 1, 2
  • ≥10 mm induration is positive in moderate-risk individuals:

    • Recent immigrants from high TB prevalence countries
    • Injection drug users
    • Residents and employees of high-risk congregate settings (prisons, nursing homes)
    • Healthcare workers
    • Children under 4 years of age
    • Persons with clinical conditions that increase TB risk (diabetes, silicosis, end-stage renal disease) 1, 2
  • ≥15 mm induration is positive in persons with no known risk factors for TB 1, 2

Clinical Applications

  • The primary purpose is to identify individuals with latent tuberculosis infection who may benefit from preventive therapy 2
  • The test is particularly important for screening high-risk populations such as healthcare workers, correctional facility residents, and immunocompromised patients 1, 2
  • For healthcare workers, baseline PPD testing should be performed during pre-employment examinations 1, 2
  • A positive test requires follow-up with chest radiography and clinical evaluation to exclude active TB before initiating treatment for latent TB infection 1, 2

Special Considerations

Two-Step Testing

  • Two-step testing is recommended for initial screening of individuals who will undergo periodic testing (e.g., healthcare workers) 1, 2
  • This process identifies the "booster phenomenon" where an initial negative test may stimulate the immune system to respond to a second test 1-3 weeks later 2
  • Without two-step testing, this boosted reaction might be misinterpreted as a new infection during subsequent testing 2

BCG Vaccination

  • Previous BCG vaccination can cause false-positive PPD results but should not prevent PPD testing in individuals who need screening 2, 3
  • The larger the reaction to PPD, the greater the probability of true TB infection rather than BCG effect 3

Common Pitfalls and Limitations

  • Improper administration technique can lead to false-negative results 2, 3
  • Reading the test outside the recommended 48-72 hour window reduces accuracy 1, 2
  • Measuring erythema instead of induration leads to incorrect interpretation 1, 2, 3
  • Failure to consider risk factors when interpreting results can lead to inappropriate clinical decisions 1, 2
  • The test has limited specificity, especially in BCG-vaccinated individuals 4, 5
  • Poor return rates for test reading can be a significant practical limitation in some settings 6

Newer Alternatives

  • Interferon-gamma release assays (IGRAs) are newer blood tests that may offer advantages over the Mantoux test, including:
    • Higher specificity (not affected by BCG vaccination)
    • Requiring only a single patient visit
    • No reader bias in interpretation 4, 5
  • These tests are increasingly being used, particularly in BCG-vaccinated individuals and settings where return for PPD reading is problematic 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

PPD Screening for Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tuberculin testing: placement and interpretation.

AAOHN journal : official journal of the American Association of Occupational Health Nurses, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.